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Aims Pulmonary vein ganglia (PVG) are targets for atrial fibrillation ablation. However, the functional relevance of PVG to
the normal heart rhythm remains unclear. Our aim was to investigate whether PVG can modulate sinoatrial node
(SAN) function.
Methods
and results
Forty-nine C57BL and seven Connexin40+/EGFP mice were studied. We used tyrosine-hydroxylase (TH) and choline-
acetyltransferase immunofluorescence labelling to characterize adrenergic and cholinergic neural elements. PVG
projected postganglionic nerves to the SAN, which entered the SAN as an extensive, mesh-like neural network.
PVG neurones were adrenergic, cholinergic, and biphenotypic. Histochemical characterization of two human embryonic
hearts showed similarities between mouse and human neuroanatomy: direct neural communications between PVG and
SAN. In Langendorff perfused mouse hearts, PVG were stimulated using 200–2000 ms trains of pulses (300 ms, 400 mA,
200 Hz). PVG stimulation caused an initial heart rate (HR) slowing (36+9%) followed by acceleration. PVG stimulation
in the presence of propranolol caused HR slowing (43+13%) that was sustained over 20 beats. PVG stimulation with
atropine progressively increased HR. Time-course effects were enhanced with 1000 and 2000 ms trains (P, 0.05 vs.
200 ms). In optical mapping, PVG stimulation shifted the origin of SAN discharges. In five paroxysmal AF patients under-
going pulmonary vein ablation, application of radiofrequency energy to the PVG area during sinus rhythm produced a
decrease in HR similar to that observed in isolated mouse hearts.
Conclusion PVG have functional and anatomical biphenotypic characteristics. They can have significant effects on the electrophysio-
logical control of the SAN.
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1. Introduction
The intrinsic cardiac nervous system comprises ganglionated nerve plexi
located intramurally in the atria and ventricles.1,2 Intracardiac ganglia are
formed by heterogeneous populations of neural elements that include
not only cholinergic postganglionic neurones, but also adrenergic, affer-
ent, and interconnecting local circuit neurones.3,4 The number of ganglia
found in the heart is variable and species-dependent.5 In many mammals,
including humans, intrinsic cardiac ganglia are usually distributed at spe-
cific atrial regions around the sinoatrial node (SAN), the roots of caval
and pulmonary veins, and near the atrioventricular node.6,7 More specif-
ically, it has been shown that the general morphology of the mouse
cardiac ganglionated nerve plexus is similar to those in larger
mammals, including humans.2
It has been suggested that intrinsic cardiac ganglionated plexi exert in-
fluenceoveradjacent myocardial regions.8 –10 The SANcan beregulated
by intrinsic ganglia located in its vicinity and this regulation has been
assumed to be mainly parasympathetic.11–14 Ablation of the pulmonary
vein ganglia (PVG) has been proposed as a therapy for atrial fibrillation.15
On the other hand, pulmonary vein isolation has been shown to affect
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heart rate (HR) variability and acceleration and deceleration capacity
of HR, due to the possible destruction of PVG, indicating that PVG
are active in the control of HR.15 However, the role that these
remotely located ganglia can have in SAN modulation is not completely
understood.
Our main objective was to test the hypothesis that PVG can contrib-
ute to the control of the SAN pacemaker function. Accordingly, we used
immunohistochemistry, electrical stimulation, and optical mapping in
mouse hearts to examine the intrinsic innervation of SAN and the
PVG and the modulation of the SAN by PVG stimulation. We also exam-
ined PVG–SAN innervation in human foetal hearts and quantified the
effects of radiofrequency energy application (RFA) to the antrum of pul-
monary veins on HR.
2. Methods
An expanded section is available in Supplementary material online, Detailed
Methods. Animal-handling protocols were in accordance with the animal
care guidelines of the European Union (2010/63/EU) and the National Insti-
tutes of Health Guidelines for the Care and Use of Laboratory Animals (NIH
publication, 8thedition, 2011). All procedureswere approvedby the Univer-
sity of Michigan Committee on Use and Care of Animals (UCUCA) and the
Kaunas Bioethical Committee.
2.1 Immunohistochemistry and microscopic
examination
We used tyrosine-hydroxylase (TH) and choline-acetyltransferase (ChAT)
immunofluorescence labelling to characterize, respectively, adrenergic and
cholinergic structures in whole-mount mouse atrial preparations as
described previously.2 Additional studies were performed in two embryonic
human hearts by means of acetylcholinesterase.5 The investigation conforms
to the principles outlined in the Declaration of Helsinki.
2.2 Electrophysiological study in mice
In Langendorff perfused hearts, PVG were stimulated using high-frequency
stimulation (300 ms, 400 mA, 200 Hz) with 200–2000 ms trains of pulses.
Volume-conducted electrocardiograms were recorded to assess the
effects of PVG stimulation at the roots of the pulmonary veins on the
mouse SAN activity by measuring changes in the P–P interval. In additional
experiments, the effect of chemical stimulation of the PVG was studied with
local application of nicotine (Supplementary material Figure S3).3
2.3 Optical mapping
Epicardial optical mapping was performed in isolated hearts and in isolated
superfused atrial preparations of wild-type C57BL and Cx40+/EGFP mice.16
Recording rate was 1 kHz, and resolution 75 mm/pixel. Activation maps
were constructed before and, for the first beat, after PVG stimulation.
2.4 Human electrophysiological study
We analysed five paroxysmal AF patients who underwent ablation for PV
isolation. All patients gave informedconsent.The investigationwasapproved
by the ethics committee of Hospital General Universitario Gregorio
Maran˜o´n. The three-dimensional geometry of the left atrium and PVs was
constructed using electroanatomical mapping systems, and RF current was
applied around the PV antrum of the patients. ECG was analysed to assess
the RFA effects on P–P interval.
2.5 Statistical analysis
Values are reported as mean+ SD unless stated otherwise. Repeated mea-
sures analysis of variance with the Bonferroni test for multiple comparisons
and paired t-test were used when appropriate (SPSS, version 17.0 for
Windows). Differences were considered significant at a two-tailed P, 0.05.
3. Results
3.1 Neuroanatomical characterization
of the whole-mount atrial preparation
PVG and SAN areas were exposed, and the atria flattened. Cholinergic
structures labelled with ChAT antibodies were visualized in the red
channel (Figure 1A). Adrenergic structures labelled with TH antibodies
are in green (Figure1B). Figure1C shows both redand green channels sim-
ultaneously. The PVG are located at the roots of the pulmonary veins,
and form a circuit via interconnecting nerve fibres. Nerves emerge
from the ganglionic circuit and advance towards the SAN area (white
arrows), suggesting neuroanatomical communication between the
PVG and the SAN. We examined in further detail the structure and
the innervation of the intact mouse SAN (Supplementary material
online, Figure S1) and the PVG. Figure 1D–F shows a characterization
of the PVG. Figure 1E and F showsthe image of the ChATand TH staining,
respectively. They are merged in Figure 1D. These ganglia are biphenoty-
pic since both sympathetic and parasympathetic somas are present
within the same ganglion. Nerves advancing from these ganglia contain
both sympathetic and parasympathetic axons. Given the nature of
these ganglia, the degree of SAN innervation, and the anatomical con-
nection between the PVG and the SAN shown in Figure 1, we proceeded
to study the effects of stimulating these ganglia on HR and the activation
of the SAN.
3.2 PVG stimulation and selective
pharmacological blockade
In Figure 2, we compare the short-term effects of PVG stimulation on the
P–P interval with those of right atrial appendage (RAA) stimulation.
Three P–P intervals post-stimulation were averaged. In control
(Figure 2A), stimulation of the PVG increased the spontaneous cycle
length from 219+21 ms pre-stimulation to 296+34 ms post-
stimulation (P, 0.05). This increase was statistically significant for all
trains delivered. In Figure 2B, a similar increase in cycle length was
observed (239+2 ms pre-stimulation vs. 341+ 30 ms post-
stimulation; P, 0.05) when the stimulation was performed in the pres-
ence of propranolol. When the train duration increased to 1000, 1250,
1500, and 2000 ms, the increase in P–P interval became more pro-
nounced (P, 0.05 vs. 200 ms, Figure 2E). In Figure 2C, the mean value
of the first three P–P intervals tended to decrease when the PVG stimu-
lation was carried out in the presence of atropine for the longest trains of
stimulation (1250 and 2000 ms, P, 0.05 vs. pre-stimulation). In the
atropine + propranolol group, P–P interval remained unchanged after
PVG stimulation (Figure 2D). No differences in P–P interval were
observed before stimulation between trains within each group, indicat-
ing that the time interval for recovery used between trains was sufficient
for the pacemaker cycle to return to baseline. Likewise, RAA stimulation
did not affect cycle length. This confirms that the stimulation used was
subthreshold for atrial myocardium excitation (Figure 2A–C) and is con-
sistent with what was shown before.17,18 When we plotted Figure 2A–D
as percentage increase in P–P with respect to pre-stimulation vs. the
stimulation train duration (Figure 2E), no differences were observed
between PVG stimulation in control and PVG stimulation in the pres-
ence of propranolol.
We computed the time-course of P–P interval changes for PVG
stimulation in control, in the presence of propranolol or atropine.
Figure 3A–C shows the increase in P–P interval for the first 20 beats
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after stimulation, expressed as percentage of the pre-stimulation P–P
intervals. We used the shortest (200 ms), intermediate (1000 ms), and
longest trains (2000 ms) for this analysis. In Supplementary material
online, Figure S2, we show traces of ECG changes with PVG stimulation.
In Figure 3A, for 200 ms trains, the time-course of the response in control
was similar to that in the presence of propranolol, and a slight P–P inter-
val shortening was observed for beats 13–20 in the presence of atro-
pine. In Figure 3B, for 1000 ms trains, the effects of PVG stimulation on
the P–P interval were accentuated, and statistically different among
the three groups (P, 0.01, PVG stimulation vs. propranolol group vs.
atropine group). PVG stimulation with propranolol resulted in an
increase in cycle length that was maintained for 20 beats, whereas in
the PVG group the initial increase in P–P interval was followed by signifi-
cant acceleration after the 10th beat. In the atropine group, the decrease
in P–P interval occurred immediately after stimulation and increased
progressively towards a steady state. As shown in Figure 3C, for the
longest train duration (2000 ms), the time-course response was also dif-
ferent amongall three experimental groups (P, 0.001; PVG stimulation
vs. propranolol group vs. atropine group; Figure 3C), following similar
trends as with the 1000 ms trains. When complete autonomic blockade
was achieved, P–P interval remained unchanged after PVG stimulation
(Figure 3A–C).
Figure1 Neuroanatomical characterization of the mouse whole-mount atrial preparation and PVG (A–C). Arrowheads indicate extrinsic nerves acces-
sing the mouse heart, whereas double arrowheads point to intrinsic ganglia located at the roots of PVs. Arrows indicate nerves emerging from the PVG,
which extend to the SAN region. Boxed areas are enlarged in Supplementary material online, Figure S1. (D–F) Characterization of the PVG (green, TH; red,
ChAT). LCV, left cranial vein; LPV, left pulmonary vein; MPV, middle pulmonary vein; RPV, right pulmonary vein; CS, coronary sinus.
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3.3 Modulation of the SAN activation by
PVG stimulation
We performed epicardial optical mapping of the right atrium in eight
mice to assess whether a change in the leading pacemaker site occurred
after PVG stimulation. In 78.1% of 25 observations before stimulation,
spontaneous sinus rhythm activation originated near the SVC, where
the SAN is traditionally found. In other cases (n ¼ 7, 21.9%), the
leading pacemaker site was closer to the IVC. In all hearts, the optical
action potential duration at baseline was significantly longer in the
SAN region than in the RAA (Supplementary material online, Figure S4).
After applying a 1000 ms train, the cycle length increased from 209+
21 ms to 338+73 ms (P, 0.05 vs. pre-stimulation, N ¼ 8 hearts, n ¼
32 observations) and the leading pacemaker site shifted in 22 out of 32
observations (68.8%). Figure 4 illustrates data from two representative
experiments in which PVG stimulation produced an upward shift
(Figure 4A) and a downward shift (Figure 4B). PVG stimulation decreased
the optical APD50 in the RAA (Supplementary material online, Figure S7)
from 14.4+2.7 to 11.9+ 2.5 ms (P, 0.001 vs. pre-stimulation; n ¼ 32
observations).
3.4 Isolated atria experiments
To further characterize the origin and shift in SAN activation post-PVG
stimulation, we mapped isolated atrial preparations in three Cx40+/EGFP
mice. After PVG stimulation (1000 ms train), the cycle length increased
from 204+29 to 333+82 ms (P, 0.05 vs. pre-stimulation, N ¼ 3
hearts, n ¼ 10 observations; Figure 5A). Single-pixel recordings from
Figure 2 Immediate effects (average of three P–P intervals post-stimulation) of PVG stimulation on HR. (A) PVG stimulation (n ¼ 12); RAA stimulation
(n ¼ 23); *P, 0.05 vs. pre-stimulation. (B) PVG stimulation + propranolol (n ¼ 17); RAA stimulation + propranolol (n ¼ 24); *P, 0.05 vs.
pre-stimulation. (C ) PVG stimulation + atropine (n ¼ 13); RAA stimulation + atropine (n ¼ 16); *P, 0.05 vs. pre-stimulation. (D) PVG stimulation
atropine + propranolol (n ¼ 16); RAA stimulation atropine + propranolol (n ¼ 16); (E) *P, 0.05 vs. PVG stimulation + atropine and PVG stimulation
atropine + propranolol; #P, 0.05 vs. 200 ms train.
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the SAN area in Figure 5C before (black) and after stimulation (red) are
shown in Figure5A.Wedidnotobserve statistically significantdifferences
in cycle length between experiments in the whole heart and those in
isolated atria preparations, either during spontaneous sinus rhythm
(209+21 vs. 204+29 ms; NS) or after PVG stimulation (338+ 73
vs. 368+79 ms; NS).
PVG stimulation caused either a shift (70%; n ¼ 7) or no change (30%;
n ¼ 3) in the origin of SAN discharges. Figure 5B is a superimposition of
the confocal scan of EGFP fluorescence onto the fluorescent image
of the preparation during optical mapping. The SAN artery is visible,
and the SAN area is bordered by the EGFP-positive atrial myocytes.
A downward pacemaker shift occurred in 85.7% of observations (six
out of seven). Figure 5C shows the initial activation of the SAN with
respect to the SAN artery. Figure 5D depicts the downward shift in the
origin of the leading pacemaker site post-PVG stimulation. Neverthe-
less, the location of the leading pacemaker remained confined to the
SAN area.
3.5 Neuroanatomy of the human embryonic
atria
We analysed 15-week-old human embryonic hearts stained with the
Karnovsky–Roots acetylcholinesterase precipitation reaction as
Figure3 Time-course effects (20 beats after stimulation) of PVG stimulation with (A) 200 ms train, (B) 1000 ms train, and (C) 2000 ms train. PVG stimu-
lation (n ¼ 12); PVG stimulation + propranolol (n ¼ 17); PVG stimulation + atropine (n ¼ 12); PVG stimulation atropine + propranolol (n ¼ 16).
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described previously.19 We paid particular attention to the PVs/SAN
regions (see also Supplementary material online, Figure S8A). Figure 6A
shows direct neural communications between PVG and SAN, similar
to the mouse heart (Figure 1A–C). These data support our contention
that direct neural communications exist between PVG and the SAN.
3.6 Electrophysiological study in patients
We investigated the effects of RFA during sinus rhythm in five patients
with paroxysmal AF (58+6 years old, three males and two females)
undergoing PV isolation. Patients’ characteristics are shown in Supple-
mentary material online, Figure S8B. Figure 6C andD shows maps illustrat-
ing three-dimensional geometry of the left atrium and PVs. The red
arrows indicate the location of RFA at the roots of the left superior pul-
monary vein (LSPV, Figure 6C) and the right inferior pulmonary vein
(RIPV, Figure 6D). RFA at those specific sites led to HR slowing
because of the likely stimulation of PV ganglia. The ECG recordings
are shown in Figure 6E. The top tracings (leads II and V5) show the time-
course of HR changes in response to RFA at the LSPV and the bottom
panel shows the effects of RFA delivery at the RIPV. Quantification of
the changes in HR produced by RFA is presented in Figure 6B. The
basal HR was computed as the mean of four beats immediately before
RFA. The durations of 12 P–P intervals that followed RFA were
plotted. After RFA delivery, there was an initial decrease in HR followed
by acceleration towards basal HR. This response was similar to that
observed in isolated mouse hearts (Figure 3).
4. Discussion
We used histochemistry, electrical stimulation, and optical mapping in
mice, and electrophysiological studies in AF patients undergoing PV iso-
lation to provide mechanistic insight into the regulation of SAN by the
intracardiac ganglia at the roots of the pulmonary veins. The results
can be summarized as follows: (i) PVG contain both adrenergic and cho-
linergic somas that project their axons to the SAN; (ii) PVG stimulation
Figure4 Modulation of the SAN activation pattern induced by PVG stimulation. The leading pacemaker site shifted upwards (A) in 31.8% of observations
(seven of 22), after applying 1000 ms train of stimulation to the PVG. (B) A representative example of a downward shift after PVG stimulation. This took
place in 68.2%of observations (15 of 22). (C) The increase in cycle length after 1000 ms trains. The quantification of the shift in the site of earliest activation is
in (D). N ¼ 8 hearts, n ¼ 32 observations. SVC, superior vena cava; PV, pulmonary veins; RAA, right atrial appendage; arrows point towards the tip of the
stimulation electrode. Colour bars in (A) and (B) display the activation time in milliseconds.
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can have significant effects on the discharge rate of the SAN without the
need of extracardiac neural reflexes; (iii) pharmacological blockade
uncovered a functional parasympathetic and sympathetic role of the
PVG; (iv) stimulation of these ganglia can shift the dominant pacemaker
location of the SAN; and (v) direct radiofrequency application at the
roots of PV in patients slows the HR similar to PVG stimulation in iso-
lated mouse hearts.
4.1 Neuroanatomy of PVG and SAN
Traditionally, intracardiac ganglionic neurones have been considered to
be cholinergic, responsible for the second relay of parasympathetic
fibres to theheart.Nevertheless, anatomical evidence revealed thepres-
ence of adrenergic neurones in the mammalian intrinsic cardiac
ganglia.20 –22 In the present study, we showed that the PVG contain
both adrenergic and cholinergic neurones (Figure 1). We observed
strong similarities in the PVG neuroanatomical structure of humans
(Figure 6A) and mice (Figure 1); in both humans and mice, PVG are
located at the roots of the PVs. Most importantly, in both species,
nerves emerge from the ganglionic circuit and advance towards the
right atrium to richly innervate the SAN region and provide a direct
neuroanatomical communication between the PVG and the SAN.
Mabe and Hoover,23 using confocal scans of murine SAN stained for ves-
icularacetylcholine (ACh) transporter andTH, reported thepresenceof
noradrenergic and cholinergic nerves. This was also shown in the dog
and rabbit SAN.18,24 In those studies, tissue sectioning was done. In con-
trast, our data illustrate the undisturbed neuroanatomy of the intact
SAN and provide the first evidence for neuroanatomical connections
between the PVG and the SAN.
4.2 Effects of PVG stimulation on SAN
automaticity
The initial effect of PVG stimulation (first three P–P intervals
post-simulation) can be considered predominantly parasympathetic
(Figure 2A). Furthermore, there were no differences between PVG
Figure 5 Combined EGFP fluorescence microscopy and optical mapping in isolated atrial preparation from Cx40+/EGFP mice. (A) PVG stimulation pro-
duced an increase in the P–P interval (P, 0.05 vs. pre-stimulation, top of the panel). Representative traces of a single pixel from the SAN area on (C) are
shown before (black) and after stimulation (red). (B) EGFP fluorescence image of the SAN superimposed on the optical image of the atrial preparation. The
white arrow points to the SAN artery. Activation maps showing the site of earliest activation with respect to the SAN artery before (C ) and after PVG
stimulation (D). Colour bars in (C ) and (D) display the activation time in milliseconds.
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stimulation and PVG stimulation + propranolol (Figure 2B and E). Para-
sympathetic stimulationcauses the rapid activationof the ACh-regulated
potassium channels, and the modulation of If through the G protein-
coupled system.25 Furthermore, the decrease in HR produced by the
stimulation of the PVG indicated that the parasympathetic and sympa-
thetic effects are not simply additive and that parasympathetic slowing
of pacemaker rate dominates over sympathetic acceleration.26,27 In
the presence of atropine, an initial decrease in P–P interval was notice-
able only with the longest trains of stimulation (Figure 2C). This is consist-
ent with the relatively long latency response to sympathetic
stimulation28 compared with vagal.29
The time-course of HR change after PVG stimulation (Figure 3) indi-
cates that PVG stimulation produced an initial slowing of HR, followed
by acceleration around the 10th beat. This suggests that the balance
between both autonomic branches shifts from parasympathetic to sym-
pathetic dominance around the 10th beat. This could be explained by
three independent factors or a combination thereof: (i) the longer
latency of the sympathetic effect, with a delayed response25; (ii) a post-
synaptic mechanism by which ACh reduces the magnitude of the
response to a given adrenergic stimulus30; and (iii) the rapid decay in
parasympathetic effects once the stimulation ceases due to the rapid
breakdown of ACh by acetylcholinesterase.31
PVG stimulation in the presence of sympathetic blockade with pro-
pranolol caused a sustained decrease in HR after stimulation. The re-
sponse to parasympathetic stimulation was an instantaneous, maximal
increase in P–P interval followed by a gradual decrease towards baseline
(Figure 3). Conversely, parasympathetic blockade with atropine led to a
clear positive chronotropic effect characteristic of sympathetic stimula-
tion (Figure 3). After a latency period, the decrease in P–P interval grad-
ually developed (200 ms trains), with the most pronounced effects
apparent with the 2000 ms trains. Ng et al.31 found latency periods of
2.9+ 0.4 and 1.5+0.2 s (at 1 and 7 Hz of sympathetic nerve stimula-
tion, respectively).
It has been suggested that the intrinsic cardiac nervous system is com-
posed of parasympathetic postganglionic and sympathetic neurones.4,11
However, whether the intrinsic cardiac nervous system is formed only
by parasympathetic postganglionic neurones is still debatable.10 Here,
we provide direct evidence demonstrating that the PVG are adrenergic
Figure 6 (A) Histochemical characterization of human embryonic PV-LA and SAN whole-mount preparations. Ganglia located at the roots of the PVs
project nerve fibres (white arrows) to the SAN area. (B) Evolution of the P–P interval during control and the first 12 intervals following RFA to the PV roots
during sinus rhythm (n ¼ 5). Cartomaps showing the sitesofRFAat the rootsof the left superiorpulmonary vein (C, LSPV) and the right superiorpulmonary
vein (D, RIPV). Red arrows indicate the sites at which RFA induced slowing. (E) ECG tracings illustrate the slowing of HR during RFA at the root of the LSPV
(top) and the RIPV (bottom). RF current was applied around the PV antrum, power ,35 W (,25 W over the posterior LA), temperature ,438C.
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and cholinergic at both the neuroanatomical and functional levels. HR
changes were completely abolished with atropine and propranolol.
This argues against a significant role for an alpha adrenergic signalling
component.
4.3 Optical mapping of the SAN
PVG stimulation caused shifts in the origin of the SAN pacemaking activ-
ity. Several studies have demonstrated that autonomic stimulation can
shift the site of earliest activation of the SAN. In vivo studies in the dog
reported that stimulation of the stellate ganglia and the vagus nerve
causes, respectively, cranial and caudal shifts of the site of earliest activa-
tion.32 In isolated rabbit and canine SAN preparations, the site of earliest
activation shifted downwards, upwards, or remained the same after
nerve stimulation.33,34 This is in line with what has been recently
shown in isolated rabbit and murine SAN preparations subjected to
direct high-frequency stimulation or isoproterenol/ACh administra-
tion.18,35 Our study is the first to examine the role of PVG stimulation
on the modulation of SAN cycle length and pattern of activation. In
our whole-heart experiments, PVG stimulation caused downward
(68.2% of cases), or upward (31.8%) displacement of the earliest activa-
tion site, where the origin of the activation shifted by 0.80+ 0.23 mm
upwards or 1.14+ 0.34 mm downwards with respect to control
(Figure 4A–C). Those results are consistent with the effects of a domin-
ant parasympathetic stimulation, since it has been shown that parasym-
pathetic stimulation with high-frequency stimulation of isolated atrial
preparations or ACh infusion produced either an upward or a down-
ward shift in the leading pacemaker site.18,33–35 The mechanism by
which pacemaker shifts occur after parasympathetic stimulation has
been studied using numerical simulations.36 It was proposed that the
SAN comprises electrically coupled oscillators (pacemaker cells) with
different intrinsic firing rates. Through reciprocal phase-dependent
interactions, the coupled oscillators mutually entrain, resulting in the
emergence of an origin of activation. Those mutually entrained oscilla-
tors, or pacemaker cells, respond to exogenous perturbations such as
ACh, through changes in maximum diastolic potential, action potential
duration, and cycle length. In the simulations of Michaels et al.,36 ACh
caused a downward shift in the dominant pacemaker region, in addition
to an increase in the cycle length of the array. By the 10th beat, the array
returned to its control pattern and rate of activation.This is similar to the
experiments we have carried out (Figures 3–5). It has also been sug-
gested that nerve stimulation can produce a pacemaker shift from the
centre to the periphery of the SAN because of electrophysiological
and neuroanatomical heterogeneities inherent to the SAN.23,24,34,37
4.4 Electrophysiological study in patients
It is controversial whether RFA to the PV area during PV isolation can
stimulate PVG and produce an increase in the R–R interval, or
whether a specifically designed high-frequency stimulation protocol is
needed.15,38–40 The currently proposed mechanism is that slowing of
HR is due to the stimulation of the afferent components of the PVG,
which in turn evokes a vagal reflex upon the activation of the vagus
nerve.15,38 We were able to observe slowing of HR during PV ablation
and quantified the chronotropic response (P–P interval) after RFA to
the LSPV and RIPV during sinus rhythm. HR slowed considerably and im-
mediately afterRFAdelivery. Data fromthe isolatedmouseheart experi-
ments showed a similar behaviour upon stimulation of the PVG,
suggesting that the local neuronal circuitry between PVG and the SAN
is necessary and sufficient to significantly influence HR.
Although care should always be exerted when attempting to extrapo-
late experimental findings to the clinical situation, our results in mice
nevertheless show that PVG have functional and anatomical biphenoty-
pic characteristics, and that they have significant effects on the electro-
physiological controlof theSANwithout the needof extracardiacneural
reflexes. Ablation of the PVG has been proposed for the treatment of
atrial fibrillation.15 However, it has been shown that destruction of
PVG can result in the degeneration of ventricular innervation,41,42 and
cardiac autonomic dysfunction has been documented to last for up to
a year post-PV isolation.43 Furthermore, it has been suggested that
vagal denervation resulting from AF ablation may predispose to ven-
tricular arrhythmias.42
In the context of the overall control of cardiac function, the relevance
of the intrathoracic neuronal hierarchy has been shown to be important,
and it has become evident that cardiac indexes are affected not only by
central neurones but also by a hierarchy of peripheral autonomic neu-
rones (intrinsic cardiac ganglia, intrathoracic extracardiac ganglia) that
collectively act to match cardiac output to the body’s blood flow
demands.44 Furthermore, it hasbeen suggested thatbeat-to-beat coord-
ination of regional cardiac indexes is due, in part, to ganglia residing close
to the cardiac tissue and constitute the intrinsic cardiac nervous
system.45 This is also evident in the studyof Baueret al.,43 where possible
destruction of PVG due to AF ablation affects the autonomic control of
HR and HR variability.
On the basis of the studies discussed earlier, and our current experi-
ments, we can speculate that PV ganglia participate in modulating homeo-
static HR, independently of the sensory information, the loop reflexes,
and also the sympathetic/parasympathetic connections with the central
nervous system. More studies will be needed to further substantiate the
pathophysiological relevance of these ganglia, and to improve therapeutic
interventions targeting the PV region in patients with AF.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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